Axinn Advises McKesson on $875M Acquisition of Rx Savings Solutions
September 19, 2022
Axinn is representing McKesson Corporation (NYSE: MCK), a diversified health care services leader, in its $875M acquisition of Rx Savings Solutions, a prescription price transparency and benefit insight company. Announced on September 19, 2022, the acquisition will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. The Axinn team is led by partners Daniel Bitton and Jeny Maier, and assisted by associate Neelesh Moorthy.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Pro Bono Partnership 28th Anniversary Gala
Sponsorship
Antitrust
Ronald McDonald House New York Together in Gold Annual Gala
Sponsorship
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust